Form 4: Aspen Aerogels Director Rebecca Blalock Receives Stock and Options Grant

Director Rebecca Blalock received stock and options as part of her annual equity grant for service as a non-employee director of Aspen Aerogels.

Summary

• On May 30, 2024, Rebecca Blalock, a director of Aspen Aerogels, received 1,898 shares of common stock and options to purchase 1,657 shares of common stock.
• The stock and options were granted as part of her annual equity compensation for serving as a non-employee director.
• The restricted shares and options will vest on the earlier of May 30, 2025, or the day before the company's 2025 annual meeting of stockholders.
• Following the transaction, Blalock directly owns 63,175 shares of Aspen Aerogels common stock and options to purchase 1,657 shares.

Sentiment

Score: 7

Explanation: The document reflects a neutral but positive sentiment as it details standard director compensation practices, indicating stable corporate governance.

Positives

• The grant of stock and options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service on the board.

Industry Context

This filing is a routine disclosure of equity compensation for a non-employee director, which is a common practice among publicly traded companies to attract and retain qualified board members.

Comparison to Industry Standards

• Equity compensation for non-employee directors varies widely based on company size, industry, and performance.
• Typically, director compensation packages include a mix of cash retainers, meeting fees, and equity grants.
• The vesting schedule of the restricted shares and options is standard, aligning with industry norms for director compensation.

Stakeholder Impact

• The equity grant aligns the director's interests with those of shareholders, potentially leading to better corporate governance and decision-making.

Key Dates